
Sign up to save your podcasts
Or
Insight on the necessary careful selection of patients with HFmrEF/HFpEF to those who are most likely to benefit from mineralocorticoid receptor antagonists. You can read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2801.
3.9
99 ratings
Insight on the necessary careful selection of patients with HFmrEF/HFpEF to those who are most likely to benefit from mineralocorticoid receptor antagonists. You can read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2801.
315 Listeners
107 Listeners
171 Listeners
497 Listeners
3,323 Listeners
258 Listeners
1,103 Listeners
719 Listeners
195 Listeners
159 Listeners
251 Listeners
253 Listeners
187 Listeners
4,441 Listeners
235 Listeners